Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Baker Brothers Life Sciences Lp
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   28,278,373    

Indirect Shares

  99,473,529      
Direct Value   $947,749,846    

Indirect Value

  $2,892,026,755      
Total Shares   127,751,902      
Total Value   $3,839,776,601      


Synageva BioPharma Corp
 $0 XOMA Corporation
 $333,213,218 Genomic Health Inc
 $576,459,614 Acadia Pharmaceuticals Inc
 $3,178,868 Incyte Corp
 $7,009,716 Alexion Pharmaceuticals Inc
 $24,083,248 Beigene Ltd
 $3,231,765 Kiniksa Pharmaceuticals, Ltd.
 $573,418 Synageva BioPharma Corp
 $0 XOMA Corporation
 $333,213,218 Genomic Health Inc
 $576,459,614 Acadia Pharmaceuticals Inc
 $3,178,868 Incyte Corp
 $7,009,716 Alexion Pharmaceuticals Inc
 $24,083,248 Beigene Ltd
 $3,231,765 Kiniksa Pharmaceuticals, Ltd.
 $573,418
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    13   
    1    

     Stock price went up :

    11   
    0    
     Stock price went down :
    2   
    1    
   
     Gain/Loss Ratio :
   5.5   
   -1.0   
     Percentage Gain/Loss :
   19.7%
 -23.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA Director 2012-07-13 5,077,676 0    Premium*  
            XOMA Corporation XOMA Director 2012-07-19 13,606,093 0    Premium*  
            Genomic Health Inc GHDX Director 2012-07-26 9,086,690 0    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2023-06-01 205,752 2023-06-01 39,330,977    Premium*  
            Seagen Inc SGEN Former 10% Owner, Dire... 2023-12-14 0 2023-12-14 0    Premium*  
            Incyte Corp INCY Director, 10% Owner 2017-09-08 119,681 2017-09-08 822,826    Premium*  
            Aceragen, Inc ACGN Director 0 2014-03-10 1,613,076    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2017-06-15 131,963 2017-06-15 1,074,556    Premium*  
            Beigene Ltd BGNE Director, 10% Owner 2023-11-14 20,838 2023-11-14 9,878,124    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 2021-11-18 0 2021-11-18 7,625,425    Premium*  
            Tscan Therapeutics, Inc. TCRX Director, 10% Owner 2022-05-10 0 2022-05-11 2,528,583    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 2022-06-13 0 2022-06-13 29,190,248    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA Director 2023-06-06 29,680 2023-06-06 2,719,343    Premium*  
            Igm Biosciences, Inc. IGMS Director 2023-06-30 0 2023-09-29 2,896,968    Premium*  
            Madrigal Pharmaceuticals Inc MDGL Director 2023-11-14 0 2023-12-14 1,793,403    Premium*  
* Premium Members only  

Records found :    114         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
SGEN Seagen Inc Director   –       •       •   2017-05-15 4 OE $10.20 $204,000 I/I 20,000 40,895,092 0 -
KNSA Kiniksa Pharmaceuticals, ... Director   –       •      –    2022-06-29 4 A $0.00 $0 I/I 20,000 2,710,597 0 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-12-14 4 B $226.97 $4,710,893 I/I 20,633 1,793,403 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-20 4 B $181.93 $3,846,575 I/I 20,709 1,607,668 2.1 %
SGEN Seagen Inc Director   –       •       •   2015-03-04 4 B $34.79 $822,418 I/I 23,621 24,723,100 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-01 4 B $31.24 $756,112 I/I 24,200 36,007,250 2.25 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2023-05-23 4 OE $17.01 $425,250 I/I 25,000 38,620,261 0 -
TCRX Tscan Therapeutics, Inc. Director   –       •       •   2022-05-11 4 B $1.99 $51,350 I/I 25,865 2,528,583 2.25 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2023-06-01 4 A $0.00 $0 I/I 26,608 39,330,977 0 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2023-01-12 4 OE $5.22 $156,600 I/I 30,000 38,484,981 0 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-14 4 B $156.42 $5,347,837 I/I 34,188 1,531,757 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-12-12 4 B $205.32 $7,548,616 I/I 34,578 1,699,129 2.1 %
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-14 4 B $152.21 $5,799,653 I/I 37,660 1,500,227 2.1 %
SGEN Seagen Inc Director   –       •       •   2016-02-26 4 B $30.13 $1,334,945 I/I 44,300 35,758,535 2.25 -
MDGL Madrigal Pharmaceuticals ... Director   –       •      –    2023-11-17 4 B $167.63 $8,100,704 I/I 46,370 1,588,541 2.1 %
SGEN Seagen Inc Former 10% Owner   –       •      –    2023-12-14 4 D $229.00 $10,661,553 D/D (46,557) 0 0 -
SGEN Seagen Inc Director   –       •       •   2015-05-07 4 B $37.07 $1,772,790 I/I 47,717 26,040,800 2.25 -
BGNE Beigene Ltd Director   –       •       •   2017-10-13 4 D $0.00 $0 I/I (49,200) 0 0 -
SGEN Seagen Inc Director   –       •       •   2016-09-12 4 B $49.84 $2,551,111 I/I 49,889 39,305,533 2.25 -
TLIS Talis Biomedical Corp Director   –       •       •   2021-11-18 4 B $4.37 $218,250 I/I 50,000 7,053,176 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-11-07 4 B $58.74 $3,301,345 I/I 56,200 40,590,914 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-09-07 4 B $47.27 $2,889,689 I/I 59,560 38,840,624 2.25 -
INCY Incyte Corp Director   –       •       •   2017-04-27 4 OE $7.26 $435,600 I/I 60,000 787,237 0 -
SGEN Seagen Inc Director   –       •       •   2016-03-07 4 B $33.68 $2,063,918 I/I 61,265 36,682,540 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-02-25 4 B $34.46 $2,194,758 I/I 63,650 24,274,259 2.25 -

  114  Records found
  1   2  3   4   5      
  Page 2 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed